Financial Reports Latest Updates Industry Maps Economic Calendar

METLIFE INC (MET) Annual Reports

Q: Where can I read METLIFE INC (MET) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

METLIFE INC is listed on NYSE, classified by the SEC under Life Insurance (SIC 6311). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： NYSE
Fiscal year end： 12/31
SEC CIK： 1099219 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$724.0M	$604.0M	+19.9%
Operating income	$1.6B	$1.4B	+15.1%
Net income	$736.0M	$729.0M	+1.0%
EPS (diluted)	$1.09	$1.03	+5.8%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In bn (USD)

Revenue 0.72 bn Net income 0.74 bn

Show table：Income statement

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	10.2	8.27	10.2	12.3	13.2	14.3	12.4	12.8	15.9	17.1	20.5	16.8	15.9	18.4	16.5	17.3	17.7	15.7	16.3	18.5	17.1	18.3	18.9	19.1	18.7	16.2	18.0	17.0	18.4	15.2	17.7	12.1	16.3	17.3	16.1	15.8	0.32	0.33	0.33	15.7	0.34	0.32	0.31	17.1	0.35	0.32	0.33	19.4	0.52	0.51	0.52	0.53	0.55	0.53	0.51	15.6	0.56	0.55	0.55	19.0	0.58	0.56	0.55	0.56	0.61	0.6	0.62	0.6	0.73	0.72
Operating income	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	5.98	—	—	—	5.72	1.40	1.66	1.44	1.49	1.42	1.39	1.65	1.68	1.63	1.60
Net income	-0.54	-1.40	-0.62	0.32	0.84	1.56	0.32	0.08	1.01	1.24	3.58	1.16	-0.14	2.30	-0.95	0.13	0.99	0.5	0.97	0.91	1.33	1.37	2.09	1.52	2.16	1.12	1.20	0.83	2.20	0.11	0.58	-2.09	0.83	0.88	-0.08	2.32	1.25	0.89	0.91	2.07	1.38	1.74	2.18	0.59	4.40	0.14	0.71	0.16	0.36	3.41	1.58	1.21	0.67	0.13	0.4	1.58	0.08	0.4	0.49	0.61	0.87	0.95	1.34	1.27	0.95	0.73	0.9	0.81	1.19	0.74

Balance sheet

Quarterly · In bn (USD)

Total assets 759 bn Total liabilities 731 bn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Total assets	—	509	535	539	566	574	617	731	751	771	785	800	820	825	846	837	842	816	823	885	891	911	909	902	920	898	882	878	917	943	953	899	915	925	721	720	713	706	698	688	713	732	743	740	738	768	780	795	770	773	762	760	724	663	650	667	674	677	652	688	678	676	705	677	688	702	720	745	743	759
Total liabilities	—	482	501	506	529	534	570	682	701	718	724	739	760	762	782	772	777	755	761	822	824	841	837	830	845	828	811	809	841	863	874	831	847	856	664	661	656	653	647	635	654	668	674	674	667	692	707	720	704	704	692	692	670	626	625	639	642	647	626	657	649	648	674	650	661	675	691	716	715	731
Equity	23.4	27.3	34.3	33.1	35.8	39.4	46.4	48.6	49.8	53.3	60.4	59.8	58.7	62.4	64.0	64.5	64.5	60.0	60.9	61.5	65.8	69.6	70.8	72.0	73.8	69.4	70.5	68.0	75.8	79.2	78.3	67.3	67.9	69.5	56.7	58.7	56.3	53.6	51.6	52.7	58.5	63.8	68.4	66.1	70.2	75.7	73.3	74.6	65.9	69.1	69.0	67.5	54.0	37.1	25.1	27.0	32.2	30.3	25.7	30.0	28.5	27.3	30.9	27.4	27.5	27.7	28.9	28.4	27.3	27.4

Cash flow

Quarterly · In bn (USD)

Operating 2.23 bn Investing -8.87 bn Financing 3.22 bn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-0.98	-0.24	3.95	1.09	2.87	1.06	1.26	2.80	3.50	3.29	2.25	1.25	5.76	6.34	3.19	1.87	2.73	4.58	2.67	6.15	2.48	4.44	4.03	5.43	2.69	4.20	2.64	4.60	1.96	4.29	2.93	5.64	2.10	3.40	4.73	2.05	1.30	5.61	3.53	1.30	2.07	2.39	4.15	5.18	1.85	0.85	3.79	5.15	1.50	2.25	3.51	5.34	1.95	4.44	4.28	2.53	2.03	3.04	3.48	5.18	2.33	3.49	4.17	4.61	4.26	2.19	3.57	7.08	2.69	2.23
Investing	-1.62	-7.26	1.52	-6.58	-7.60	-2.52	-9.25	1.06	-8.09	-8.80	-6.45	1.11	2.17	-14.9	-1.30	2.15	-9.72	1.87	1.28	-8.59	2.16	-8.86	-4.97	-3.39	-6.90	0.14	-0.15	-3.49	-5.74	-4.17	-4.68	8.74	-4.28	-2.87	-10.0	0.28	-0.48	-4.28	-6.23	5.36	-5.70	0.56	-5.35	-7.09	-8.34	-1.39	-6.68	-2.16	-1.05	1.01	-8.28	-2.86	-0.43	2.12	-4.11	-0.2	-1.50	-6.35	-2.97	0.58	-2.63	-1.34	-2.16	-5.36	-3.32	-2.98	-5.02	-4.29	-5.45	-8.87
Financing	-2.17	1.17	-3.12	0.02	3.85	3.02	11.8	-5.25	2.26	4.32	4.60	-1.80	0.24	6.05	-1.04	-5.22	1.32	-7.11	-1.79	-1.32	-3.66	3.23	2.41	0.28	1.72	-4.29	-0.29	1.56	4.24	3.38	0.61	-11.8	1.50	-0.69	0.88	-2.59	0.22	1.39	-1.08	-3.33	2.32	0.93	2.33	-1.01	14.2	0.68	2.89	-6.99	-0.56	1.63	-1.11	-1.33	1.95	-9.13	1.78	-4.70	-2.29	0.38	-0.85	-0.18	-0.26	-1.20	-1.15	-0.52	0.22	1.45	-0.51	-1.00	3.56	3.22
Cash at period end	19.4	13.2	15.6	10.1	9.20	10.7	14.6	13.1	10.7	9.63	10.0	10.5	18.7	16.0	16.9	15.7	9.98	9.18	11.4	7.59	8.57	7.39	8.78	10.8	8.13	8.07	10.2	12.8	13.3	17.1	15.9	17.9	17.4	17.3	13.0	12.7	13.9	16.3	12.5	15.8	14.5	18.4	19.4	16.6	24.1	24.3	24.4	19.8	19.6	25.0	19.0	20.1	23.5	20.6	22.2	20.2	18.5	15.4	14.9	20.6	19.8	20.8	21.8	20.1	21.3	22.2	20.2	22.0	22.7	19.3

Profitability

Quarterly · %

Operating margin 221.6% Net margin 101.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	38.3%	—	—	—	30.1%	242.8%	297.9%	260.3%	268.2%	231.6%	230.6%	265.7%	279.8%	222.2%	221.6%
Net margin	-5.3%	-17.0%	-6.1%	2.6%	6.3%	10.9%	2.5%	0.6%	6.3%	7.2%	17.5%	6.9%	-0.9%	12.5%	-5.8%	0.7%	5.6%	3.2%	6.0%	4.9%	7.8%	7.5%	11.1%	8.0%	11.5%	6.9%	6.7%	4.9%	11.9%	0.7%	3.3%	-17.3%	5.1%	5.1%	-0.5%	14.6%	389.1%	271.6%	277.2%	13.2%	409.8%	537.4%	697.8%	3.5%	1274.8%	44.8%	213.3%	0.8%	69.5%	662.8%	307.0%	227.8%	121.6%	25.1%	77.3%	10.1%	14.2%	73.6%	88.3%	3.2%	150.3%	169.5%	242.2%	228.6%	154.7%	120.7%	144.3%	134.8%	161.4%	101.7%

Returns & leverage

Quarterly · %

ROE 13.2% ROA 0.5% Debt ratio 96.3%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-6.8%	-2.9%	6.3%	7.5%	6.8%	6.9%	5.7%	11.1%	12.9%	10.8%	11.9%	3.8%	2.1%	4.0%	1.1%	4.1%	5.3%	5.7%	7.1%	8.7%	9.4%	10.2%	9.9%	8.5%	7.6%	7.2%	5.8%	5.0%	1.2%	-0.8%	0.3%	-0.7%	6.3%	7.0%	7.1%	9.9%	9.2%	9.2%	10.4%	12.3%	9.9%	13.8%	10.5%	8.3%	7.7%	2.0%	6.4%	7.7%	9.2%	11.5%	6.8%	5.1%	5.9%	5.1%	7.3%	10.1%	5.5%	7.8%	10.1%	13.3%	15.4%	16.1%	15.6%	12.8%	12.1%	13.2%	13.2%
ROA	—	—	—	-0.4%	-0.1%	0.4%	0.5%	0.4%	0.5%	0.4%	0.8%	0.9%	0.7%	0.9%	0.3%	0.2%	0.3%	0.1%	0.3%	0.4%	0.4%	0.5%	0.7%	0.7%	0.8%	0.8%	0.7%	0.6%	0.6%	0.5%	0.4%	0.1%	-0.1%	0.0%	-0.1%	0.5%	0.5%	0.5%	0.8%	0.7%	0.7%	0.8%	1.0%	0.8%	1.2%	1.0%	0.8%	0.7%	0.2%	0.6%	0.7%	0.8%	0.9%	0.5%	0.3%	0.4%	0.3%	0.4%	0.4%	0.2%	0.3%	0.4%	0.6%	0.7%	0.7%	0.6%	0.5%	0.5%	0.5%	0.5%
Debt ratio	—	94.6%	93.5%	93.8%	93.6%	93.1%	92.4%	93.3%	93.3%	93.0%	92.3%	92.5%	92.8%	92.4%	92.4%	92.2%	92.3%	92.6%	92.5%	92.9%	92.5%	92.3%	92.1%	92.0%	91.9%	92.2%	92.0%	92.2%	91.7%	91.6%	91.8%	92.5%	92.5%	92.5%	92.1%	91.8%	92.1%	92.4%	92.6%	92.3%	91.8%	91.3%	90.8%	91.0%	90.5%	90.1%	90.6%	90.6%	91.4%	91.0%	90.9%	91.1%	92.5%	94.4%	96.1%	95.9%	95.2%	95.5%	96.0%	95.6%	95.8%	95.9%	95.6%	95.9%	96.0%	96.0%	95.9%	96.1%	96.3%	96.3%

EPS

Quarterly · US$

EPS US$1.09

Show table：EPS

Item	2009Q1	2009Q2	2009Q3	2009Q4	2010Q1	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	-0.71	-1.74	-0.79	0.35	0.97	1.84	0.32	0.05	0.78	1.13	3.33	1.06	-0.16	2.12	-0.92	0.09	0.87	0.43	0.84	0.77	1.14	1.17	1.81	1.30	1.87	0.92	1.06	0.70	1.98	0.06	0.51	-1.94	0.75	0.77	-0.08	2.14	1.19	0.83	0.88	2.04	1.40	1.77	2.30	0.58	4.75	0.07	0.69	0.14	0.33	3.83	1.77	1.41	0.73	0.13	0.41	1.96	0.02	0.48	0.56	0.77	1.10	1.28	1.81	1.77	1.28	1.03	1.22	1.17	1.74	1.09

Revenue & profit

Year-to-date · In bn (USD)

Revenue 1.46 bn Net income 1.92 bn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In bn (USD)

Total assets 759 bn Total liabilities 731 bn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In bn (USD)

Operating 4.92 bn Investing -14.3 bn Financing 6.78 bn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin 221.9% Net margin 131.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 13.2% ROA 0.5% Debt ratio 96.3%

EPS

Year-to-date · US$

EPS US$2.83

Revenue & profit

Annual · In bn (USD)

Revenue 2.44 bn Net income 3.38 bn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	41.1	52.7	70.3	68.2	68.2	73.3	70.0	63.5	65.5	16.6	18.1	20.4	2.07	17.2	20.7	2.25	2.44
Operating income	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	6.00	6.14
Net income	-2.25	2.79	6.98	1.32	3.37	6.31	5.31	0.8	3.95	5.12	5.90	5.41	6.55	2.77	1.58	4.43	3.38

Balance sheet

Annual · In bn (USD)

Total assets 745 bn Total liabilities 716 bn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total assets	539	731	800	837	885	902	878	899	720	688	740	795	760	667	688	677	745
Total liabilities	506	682	739	772	822	830	809	831	661	635	674	720	692	639	657	650	716
Equity	33.1	48.6	59.8	64.5	61.5	72.0	68.0	67.3	58.7	52.7	66.1	74.6	67.5	27.0	30.0	27.4	28.4

Cash flow

Annual · In bn (USD)

Operating 17.1 bn Investing -15.6 bn Financing 0.16 bn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	3.80	8.00	10.3	17.2	16.1	16.4	14.1	14.8	12.3	11.7	13.8	11.6	12.6	13.2	13.7	14.6	17.1
Investing	-13.9	-18.3	-22.2	-11.9	-15.2	-15.1	-10.4	-5.85	-16.9	-5.63	-17.6	-18.6	-11.2	-2.62	-10.3	-11.5	-15.6
Financing	-4.10	13.4	9.38	0.04	-8.91	2.26	-1.29	-3.55	-0.91	-2.80	4.57	10.7	-1.37	-10.1	-2.94	-3.13	0.16
Cash at period end	10.1	13.1	10.5	15.7	7.59	10.8	12.8	17.9	12.7	15.8	16.6	19.8	20.1	20.2	20.6	20.1	22.0

Profitability

Annual · %

Operating margin 251.9% Net margin 138.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	267.1%	251.9%
Net margin	-5.5%	5.3%	9.9%	1.9%	4.9%	8.6%	7.6%	1.3%	6.0%	30.8%	32.6%	26.5%	316.0%	16.1%	7.6%	197.2%	138.7%

Returns & leverage

Annual · %

ROE 12.1% ROA 0.5% Debt ratio 96.1%

Show table：Returns & leverage

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-6.8%	6.8%	12.9%	2.1%	5.3%	9.4%	7.6%	1.2%	6.3%	9.2%	9.9%	7.7%	9.2%	5.9%	5.5%	15.4%	12.1%
ROA	-0.4%	0.4%	0.9%	0.2%	0.4%	0.7%	0.6%	0.1%	0.5%	0.7%	0.8%	0.7%	0.8%	0.4%	0.2%	0.7%	0.5%
Debt ratio	93.8%	93.3%	92.5%	92.2%	92.9%	92.0%	92.2%	92.5%	91.8%	92.3%	91.0%	90.6%	91.1%	95.9%	95.6%	95.9%	96.1%

EPS

Annual · US$

EPS US$4.70

Show table：EPS

Item	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	-2.89	3.18	6.30	1.13	2.91	5.42	4.55	0.61	3.58	4.94	6.05	5.65	7.34	3.23	1.83	5.96	4.70

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read METLIFE INC (MET) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.